18F-FDG PET/CT Imaging of Hidradenocarcinoma Arising From Preexisting Hidradenoma of the Knee. 2018

Tirth V Patel, and Jorge Oldan
From the Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC.

Malignant tumors of the sweat glands are exceedingly rare and aggressive tumors. We present here a case of a 60-year-old man with a malignant hidradenocarcinoma that developed in a background of preexisting benign hidradenoma on the lateral aspect of the knee that was initially resected, but rapidly recurred with associated inguinal lymphadenopathy. F-FDG PET/CT was performed as part of preoperative staging, which demonstrated abnormal inguinal lymph nodes and metastatic disease to the lungs. FDG PET/CT can play an invaluable role in the initial staging and follow-up of this rare malignancy.

UI MeSH Term Description Entries
D007717 Knee A region of the lower extremity immediately surrounding and including the KNEE JOINT.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072078 Positron Emission Tomography Computed Tomography An imaging technique that combines a POSITRON-EMISSION TOMOGRAPHY (PET) scanner and a CT X RAY scanner. This establishes a precise anatomic localization in the same session. CT PET,CT PET Scan,PET CT Scan,PET-CT,PET-CT Scan,Positron Emission Tomography-Computed Tomography,CT PET Scans,CT Scan, PET,CT Scans, PET,PET CT Scans,PET Scan, CT,PET Scans, CT,PET-CT Scans,Scan, CT PET,Scan, PET CT,Scan, PET-CT,Scans, CT PET,Scans, PET CT,Scans, PET-CT
D013544 Sweat Gland Neoplasms New abnormal growth of tissue in the SWEAT GLANDS. Neoplasms, Sweat Gland,Neoplasm, Sweat Gland,Sweat Gland Neoplasm
D018250 Acrospiroma A rare cutaneous tumor of apocrine or eccrine SWEAT GLAND origin. It is most commonly found on the extremities and is usually benign. It appears as a solitary nodule or cyst and may be solid or produce a watery discharge. It is related to POROMA except in acrospiroma it does not involve the epidermis. There is no indication that heredity or external agents cause these tumors. Acrospiroma, Eccrine,Eccrine Spiradenoma,Hidradenoma,Spiradenoma,Clear-Cell Hidradrenoma,Cystic Hidradenoma,Eccrine Acrospiroma,Nodular Hidradrenoma,Solid-Cystic Hidradenoma,Acrospiromas,Clear Cell Hidradrenoma,Clear-Cell Hidradrenomas,Cystic Hidradenomas,Eccrine Acrospiromas,Eccrine Spiradenomas,Hidradenoma, Cystic,Hidradenoma, Solid-Cystic,Hidradenomas,Hidradrenoma, Clear-Cell,Hidradrenoma, Nodular,Hidradrenomas, Nodular,Nodular Hidradrenomas,Solid Cystic Hidradenoma,Solid-Cystic Hidradenomas,Spiradenoma, Eccrine,Spiradenomas,Spiradenomas, Eccrine
D019788 Fluorodeoxyglucose F18 The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162) 18F Fluorodeoxyglucose,18FDG,2-Fluoro-2-deoxy-D-glucose,2-Fluoro-2-deoxyglucose,Fludeoxyglucose F 18,18F-FDG,Fluorine-18-fluorodeoxyglucose,Fluorodeoxyglucose F 18,2 Fluoro 2 deoxy D glucose,2 Fluoro 2 deoxyglucose,F 18, Fludeoxyglucose,F 18, Fluorodeoxyglucose,F18, Fluorodeoxyglucose,Fluorine 18 fluorodeoxyglucose,Fluorodeoxyglucose, 18F

Related Publications

Tirth V Patel, and Jorge Oldan
October 2008, Annales de dermatologie et de venereologie,
Tirth V Patel, and Jorge Oldan
January 2019, Revista espanola de medicina nuclear e imagen molecular,
Tirth V Patel, and Jorge Oldan
September 2021, Journal of nuclear medicine technology,
Tirth V Patel, and Jorge Oldan
June 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer,
Tirth V Patel, and Jorge Oldan
January 2011, Annals of Saudi medicine,
Tirth V Patel, and Jorge Oldan
November 2012, Clinical nuclear medicine,
Tirth V Patel, and Jorge Oldan
March 2013, Clinical nuclear medicine,
Tirth V Patel, and Jorge Oldan
September 2009, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Tirth V Patel, and Jorge Oldan
May 2020, Clinical nuclear medicine,
Tirth V Patel, and Jorge Oldan
July 2020, Clinical nuclear medicine,
Copied contents to your clipboard!